Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis

Antimicrob Agents Chemother. 2009 Nov;53(11):4911-4. doi: 10.1128/AAC.00703-09. Epub 2009 Aug 31.

Abstract

Comparison of the quinolone resistance-determining regions (QRDRs) in 42 Mycoplasma bovis clinical isolates revealed amino acid substitutions at both GyrA (position 83) and ParC (position 84) in 10/11 enrofloxacin-resistant strains. The mutation present in the parC QRDR was discriminative for enrofloxacin resistance by parC PCR-restriction fragment length polymorphism. Comparison of molecular profiles by insertion sequence typing suggests that the currently prevalent enrofloxacin-resistant M. bovis strain evolved by selection under field conditions from one of the susceptible strains.

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • DNA Topoisomerase IV / genetics*
  • Enrofloxacin
  • Fluoroquinolones / pharmacology*
  • Microbial Sensitivity Tests
  • Mycoplasma bovis / drug effects*
  • Mycoplasma bovis / genetics*
  • Point Mutation*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Enrofloxacin
  • DNA Topoisomerase IV